The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Metabolomics tools for identifying biomarkers for neuropsychiatric diseases
Open accessAbstract
The repertoire of biochemicals (or small molecules) present in cells, tissue, and body fluids is known as the metabolome. Today, clinicians utilize only a very small part of the information contained in the metabolome, as revealed by the quantification of a limited set of analytes to gain information on human health. Examples include measuring glucose or cholesterol to monitor diabetes and cardiovascular health, respectively. With a focus on comprehensively studying the metabolome, the rapidly growing field of metabolomics captures the metabolic state of organisms at the global or "-omics" level. Given that the overall health status of an individual is captured by his or her metabolic state, which is a reflection of what has been encoded by the genome and modified by environmental factors, metabolomics has the potential to have a great impact upon medical practice by providing a wealth of relevant biochemical data. Metabolomics promises to improve current, single metabolites-based clinical assessments by identifying metabolic signatures (biomarkers) that embody global biochemical changes in disease, predict responses to treatment or medication side effects (pharmachometabolomics). State of the art metabolomic analytical platforms and informatics tools are being used to map potential biomarkers for a multitude of disorders including those of the central nervous system (CNS). Indeed, CNS disorders are linked to disturbances in metabolic pathways related to neurotransmitter systems (dopamine, serotonin, GABA and glutamate); fatty acids such as arachidonic acid-cascade; oxidative stress and mitochondrial function. Metabolomics tools are enabling us to map in greater detail perturbations in many biochemical pathways and links among these pathways this information is key for development of biomarkers that are disease-specific. In this review, we elaborate on some of the concepts and technologies used in metabolomics and its promise for biomarker discovery. We also highlight early findings from metabolomic studies in CNS disorders such as schizophrenia, Major Depressive Disorder (MDD), Bipolar Disorder (BD), Amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
Mass spectrometry‐based metabolomics
Dettmer, K., Aronov, P. A., & Hammock, B. D. (2007) · Mass Spectrometry Reviews · doi:10.1002/mas.20108 · Cited by 2,241
Beckonert, O., Keun, H. C., Ebbels, T. M. D., Bundy, J., Holmes, E., Lindon, J. C., & Nicholson, J. K. (2007) · Nature Protocols · doi:10.1038/nprot.2007.376 · Cited by 2,109
HMDB: a knowledgebase for the human metabolome
Wishart, D. S., Knox, C., Guo, A. C., Eisner, R., Young, N., Gautam, B., Hau, D. D., Psychogios, N., Dong, E., Bouatra, S., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn810 · Cited by 1,873
Concordance among Gene-Expression–Based Predictors for Breast Cancer
Fan, C., Oh, D. S., Wessels, L., Weigelt, B., Nuyten, D. S. A., Nobel, A. B., van't Veer, L. J., & Perou, C. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052933 · Cited by 1,341
The emerging field of lipidomics
Wenk, M. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1776 · Cited by 1,330
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan, R. S. (2006) · Circulation · doi:10.1161/circulationaha.104.482570 · Cited by 1,212
Systems Biology and New Technologies Enable Predictive and Preventative Medicine
Hood, L., Heath, J. R., Phelps, M. E., & Lin, B. (2004) · Science · doi:10.1126/science.1104635 · Cited by 1,108
Human metabolic phenotype diversity and its association with diet and blood pressure
Holmes, E., Loo, R. L., Stamler, J., Bictash, M., Yap, I. K. S., Chan, Q., Ebbels, T., De Iorio, M., Brown, I. J., Veselkov, K. A., et al. (2008) · Nature · doi:10.1038/nature06882 · Cited by 1,054
Prabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 971
Metabolic Phenotyping in Health and Disease
Holmes, E., Wilson, I. D., & Nicholson, J. K. (2008) · Cell · doi:10.1016/j.cell.2008.08.026 · Cited by 822
Metabolomics: A Global Biochemical Approach to Drug Response and Disease
Kaddurah-Daouk, R., Kristal, B. S., & Weinshilboum, R. M. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094715 · Cited by 670
Self-citationMetabolomics: Current technologies and future trends
Hollywood, K., Brison, D. R., & Goodacre, R. (2006) · PROTEOMICS · doi:10.1002/pmic.200600106 · Cited by 604
Metabolomics and systems biology: making sense of the soup
KELL, D. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.04.012 · Cited by 529
The Limits of Reductionism in Medicine: Could Systems Biology Offer an Alternative?
Ahn, A. C., Tewari, M., Poon, C.-S., & Phillips, R. S. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030208 · Cited by 510
Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers
Trusheim, M. R., Berndt, E. R., & Douglas, F. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2251 · Cited by 509
Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia
Sabatine, M. S., Liu, E., Morrow, D. A., Heller, E., McCarroll, R., Wiegand, R., Berriz, G. F., Roth, F. P., & Gerszten, R. E. (2005) · Circulation · doi:10.1161/circulationaha.105.569137 · Cited by 461
The Metabolomics Standards Initiative
MSI Board Members: (2007) · Nature Biotechnology · doi:10.1038/nbt0807-846b · Cited by 454
Machine Learning for Detection and Diagnosis of Disease
Sajda, P. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095802 · Cited by 409
Metabolomics technology and bioinformatics
Shulaev, V. (2006) · Briefings in Bioinformatics · doi:10.1093/bib/bbl012 · Cited by 408
Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders
DeKosky, S. T., & Marek, K. (2003) · Science · doi:10.1126/science.1090349 · Cited by 406
Metabolomic profiling to develop blood biomarkers for Parkinson's disease
Bogdanov, M., Matson, W. R., Wang, L., Matson, T., Saunders-Pullman, R., Bressman, S. S., & Beal, M. F. (2008) · Brain · doi:10.1093/brain/awm304 · Cited by 401
Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis
(2003) · Springer eBooks · doi:10.1007/978-1-4615-0333-0 · Cited by 390
Global systems biology, personalized medicine and molecular epidemiology
Nicholson, J. K. (2006) · Molecular Systems Biology · doi:10.1038/msb4100095 · Cited by 388
Prabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J. T.-J., Griffin, J. L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001532 · Cited by 375
Olfactory loss may be a first sign of idiopathic Parkinson's disease
Haehner, A., Hummel, T., Hummel, C., Sommer, U., Junghanns, S., & Reichmann, H. (2007) · Movement Disorders · doi:10.1002/mds.21413 · Cited by 333
Detection of epithelial ovarian cancer using 1H‐NMR‐based metabonomics
Odunsi, K., Wollman, R. M., Ambrosone, C. B., Hutson, A., McCann, S. E., Tammela, J., Geisler, J. P., Miller, G., Sellers, T., Cliby, W., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.20651 · Cited by 317
NMR-Based Metabolic Profiling and Metabonomic Approaches to Problems in Molecular Toxicology
Coen, M., Holmes, E., Lindon, J. C., & Nicholson, J. K. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700335d · Cited by 304
Metabolomics: from pattern recognition to biological interpretation
Weckwerth, W., & Morgenthal, K. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03609-3 · Cited by 298
Systems biology, metabolic modelling and metabolomics in drug discovery and development
Kell, D. B. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.004 · Cited by 297
Spectroscopic and Statistical Techniques for Information Recovery in Metabonomics and Metabolomics
Lindon, J. C., & Nicholson, J. K. (2008) · Annual Review of Analytical Chemistry · doi:10.1146/annurev.anchem.1.031207.113026 · Cited by 294
Holmes, E., Tsang, T. M., Huang, J. T.-J., Leweke, F. M., Koethe, D., Gerth, C. W., Nolden, B. M., Gross, S., Schreiber, D., Nicholson, J. K., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030327 · Cited by 290
Dunn, W. B. (2008) · Physical Biology · doi:10.1088/1478-3975/5/1/011001 · Cited by 278
Summary recommendations for standardization and reporting of metabolic analyses
The Standard Metabolic Reporting Structures working group (2005) · Nature Biotechnology · doi:10.1038/nbt0705-833 · Cited by 275
Metabolomic Mapping of Atypical Antipsychotic Effects in Schizophrenia
Kaddurah-Daouk, R., McEvoy, J., Baillie, R. A., Lee, D., Yao, J. K., Doraiswamy, P. M., & Krishnan, K. R. R. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002000 · Cited by 262
The role of analytical sciences in medical systems biology
Greef, J. V. D., Stroobant, P., & Heijden, R. V. D. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.08.013 · Cited by 262
Evidence of different metabolic phenotypes in humans
Assfalg, M., Bertini, I., Colangiuli, D., Luchinat, C., Schäfer, H., Schütz, B., & Spraul, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705685105 · Cited by 258
Applications of Metabolomics in Drug Discovery and Development
Wishart, D. S. (2008) · Drugs in R & D · doi:10.2165/00126839-200809050-00002 · Cited by 247
Extending the breadth of metabolite profiling by gas chromatography coupled to mass spectrometry
Fiehn, O. (2008) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2008.01.007 · Cited by 240
Metabolomics: current state and evolving methodologies and tools
Oldiges, M., Lütz, S., Pflug, S., Schroer, K., Stein, N., & Wiendahl, C. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-007-1029-2 · Cited by 238
YANG, J., XU, G., ZHENG, Y., KONG, H., PANG, T., LV, S., & YANG, Q. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.09.032 · Cited by 210
A role for fMRI in optimizing CNS drug development
Borsook, D., Becerra, L., & Hargreaves, R. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2027 · Cited by 203
The Art and Practice of Systems Biology in Medicine: Mapping Patterns of Relationships
van der Greef, J., Martin, S., Juhasz, P., Adourian, A., Plasterer, T., Verheij, E. R., & McBurney, R. N. (2007) · Journal of Proteome Research · doi:10.1021/pr0606530 · Cited by 201
The Clinical Applications of a Systems Approach
Ahn, A. C., Tewari, M., Poon, C.-S., & Phillips, R. S. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030209 · Cited by 198
Identifying Functional Neuroimaging Biomarkers of Bipolar Disorder: Toward DSM-V
Phillips, M. L., & Vieta, E. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm060 · Cited by 196
Brindle, J. T., Nicholson, J. K., Schofield, P. M., Grainger, D. J., & Holmes, E. (2003) · The Analyst · doi:10.1039/b209155k · Cited by 191
Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles
Underwood, B. R., Broadhurst, D., Dunn, W. B., Ellis, D. I., Michell, A. W., Vacher, C., Mosedale, D. E., Kell, D. B., Barker, R. A., Grainger, D. J., et al. (2006) · Brain · doi:10.1093/brain/awl027 · Cited by 183
Metabolomics-Based Systems Biology and Personalized Medicine: Moving Towards n = 1 Clinical Trials?
van der Greef, J., Hankemeier, T., & McBurney, R. N. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.7.1087 · Cited by 175
Metabonomics and its role in drug development and disease diagnosis
Lindon, J. C., Holmes, E., & Nicholson, J. K. (2004) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.4.2.189 · Cited by 174
Nutritional effects on blood pressure
Myers, V. H., & Champagne, C. M. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328012d911 · Cited by 170
Coen, M., Ruepp, S. U., Lindon, J. C., Nicholson, J. K., Pognan, F., Lenz, E. M., & Wilson, I. D. (2004) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2003.12.019 · Cited by 164
A metabolome pipeline: from concept to data to knowledge
Brown, M., Dunn, W. B., Ellis, D. I., Goodacre, R., Handl, J., Knowles, J. D., O’Hagan, S., Spasić, I., & Kell, D. B. (2005) · Metabolomics · doi:10.1007/s11306-005-1106-4 · Cited by 162
Beckonert, O. P., Monnerjahn, J., Bonk, U., & Leibfritz, D. (2003) · NMR in Biomedicine · doi:10.1002/nbm.797 · Cited by 160
Yi, L., He, J., Liang, Y., Yuan, D., & Chau, F. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.11.043 · Cited by 155
Lipidomics: Practical aspects and applications
Wolf, C., & Quinn, P. J. (2007) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.09.001 · Cited by 154
Leoni, V., Masterman, T., Patel, P., Meaney, S., Diczfalusy, U., & Björkhem, I. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200434-jlr200 · Cited by 152
Dumas, M., Wilder, S. P., Bihoreau, M., Barton, R. H., Fearnside, J., Argoud, K., D’Amato, L., Wallis, R. H., Blancher, C., Keun, H. C., et al. (2007) · Nature Genetics · doi:10.1038/ng2026 · Cited by 151
Metabolomic analysis and signatures in motor neuron disease
Rozen, S., Cudkowicz, M., Bogdanov, M. B., Matson, W. R., Kristal, B. S., Beecher, C., Harrison, S. J., Vouros, P., Flarakos, J., Vigneau-Callahan, K. E., et al. (2005) · Metabolomics · doi:10.1007/s11306-005-4810-1 · Cited by 146
Self-citationWilliams, R. E., Lenz, E. M., Wilson, A., et al. (2006) · Molecular BioSystems · doi:10.1039/b516356k · Cited by 140
A preliminary metabolomic analysis of older adults with and without depression
Paige, L. A., Mitchell, M. W., Krishnan, K. R. R., Kaddurah‐Daouk, R., & Steffens, D. C. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1690 · Cited by 136
Self-citationWikoff, W. R., Pendyala, G., Siuzdak, G. E., & Fox, H. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34138 · Cited by 131
Tsang, T. M., Woodman, B., McLoughlin, G., Griffin, J. L., Tabrizi, S. J., Bates, G. P., & Holmes, E. C. (2006) · Journal of Proteome Research · doi:10.1021/pr050244o · Cited by 129
CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis
Huang, J. T.-J., Leweke, F. M., Tsang, T. M., Koethe, D., Kranaster, L., Gerth, C. W., Gross, S., Schreiber, D., Ruhrmann, S., Schultze‐Lutter, F., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000756 · Cited by 128
Altmaier, E., Ramsay, S. L., Graber, A., Mewes, H., Weinberger, K. M., & Suhre, K. (2008) · Endocrinology · doi:10.1210/en.2007-1747 · Cited by 127
van Doorn, M. B. A., Vogels, J., Tas, A. C., van Hoogdalem, E. J., Burggraaf, J., Cohen, A. F., & van der Greef, J. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02816.x · Cited by 125
Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning
Kenny, L. C., Dunn, W. B., Ellis, D. I., Myers, J., Baker, P. N., & Kell, D. B. (2005) · Metabolomics · doi:10.1007/s11306-005-0003-1 · Cited by 124
Emerging bioinformatics for the metabolome
Pedro, M. (2002) · Briefings in Bioinformatics · doi:10.1093/bib/3.2.134 · Cited by 124
Shin, H., & Markey, M. K. (2005) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2005.04.002 · Cited by 116
Metabolic changes in schizophrenia and human brain evolution
Khaitovich, P., Lockstone, H. E., Wayland, M. T., Tsang, T. M., Jayatilaka, S. D., Guo, A. J., Zhou, J., Somel, M., Harris, L. W., Holmes, E. C., et al. (2008) · Genome biology · doi:10.1186/gb-2008-9-8-r124 · Cited by 115
Morvan, D., & Demidem, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2346 · Cited by 109
Chemoselective probes for metabolite enrichment and profiling
Carlson, E. E., & Cravatt, B. F. (2007) · Nature Methods · doi:10.1038/nmeth1038 · Cited by 108
Biomarkers for the Early Detection of Parkinson’s and Alzheimer’s Disease
Berg, D. (2008) · Neurodegenerative Diseases · doi:10.1159/000113682 · Cited by 106
Viant, M. R., Lyeth, B. G., Miller, M. G., & Berman, R. F. (2005) · NMR in Biomedicine · doi:10.1002/nbm.980 · Cited by 103
A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease
Herting, B., Schulze, S., Reichmann, H., Haehner, A., & Hummel, T. R. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0665-5 · Cited by 102
Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia
Tkachev, D., Mimmack, M. L., Huffaker, S. J., Ryan, M., & Bahn, S. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007334 · Cited by 101
Variability in the clinical expression of Parkinson's disease
Wolters, E. C. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.08.016 · Cited by 99
Neuroimaging in Parkinson’s disease
Brooks, D. J. (2004) · NeuroRx · doi:10.1602/neurorx.1.2.243 · Cited by 96
Olfactory Dysfunction in Parkinson’s Disease
Kranick, S. M., & Duda, J. E. (2007) · Neurosignals · doi:10.1159/000109757 · Cited by 96
Rosas, H. D., Feigin, A., & Hersch, S. M. (2004) · Neurotherapeutics · doi:10.1602/neurorx.1.2.263 · Cited by 93
Relationships Between Plasma, CSF and Brain Tryptophan
Curzon, G. (1979) · Springer eBooks · doi:10.1007/978-3-7091-2243-3_7 · Cited by 80
Trauger, S. A., Kalisak, E., Kalisiak, J., Morita, H., Weinberg, M. V., Menon, A. L., Poole, F. L., Adams, M. W. W., & Siuzdak, G. E. (2008) · Journal of Proteome Research · doi:10.1021/pr700609j · Cited by 78
Maier, B., Laurer, H. L., Rose, S., Buurman, W. A., & Marzi, İ. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.822 · Cited by 75
Metabolomics Takes Its Place as Latest Up-and-Coming "Omic" Science
Schmidt, C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/96.10.732 · Cited by 69
Dunne, V. G., Bhattachayya, S., Besser, M., Rae, C. D., & Griffin, J. L. (2004) · NMR in Biomedicine · doi:10.1002/nbm.918 · Cited by 65
Molecular neuroimaging in Alzheimer’s disease
Jagust, W. (2004) · Neurotherapeutics · doi:10.1602/neurorx.1.2.206 · Cited by 62
Tsang, T. M., Huang, J. T.-J., Holmes, E. C., & Bahn, S. (2006) · Journal of Proteome Research · doi:10.1021/pr0503782 · Cited by 61
Kristal, B. S., Shurubor, Y. I., Kaddurah-Daouk, R. F., & Matson, W. R. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-244-1_10 · Cited by 56
Self-citationMeinicke, P., Lingner, T., Kaever, A., Feussner, K., Göbel, C., Feußner, I., Karlovský, P., & Morgenstern, B. (2008) · Algorithms for Molecular Biology · doi:10.1186/1748-7188-3-9 · Cited by 56
Integrative investigation of metabolic and transcriptomic data
Pir, P., Kırdar, B., Hayes, A., Önsan, Z. İ., Ülgen, K. Ö., & Oliver, S. G. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-203 · Cited by 37
Shurubor, Y. I., Matson, W. R., Willett, W. C., Hankinson, S. E., & Kristal, B. S. (2007) · BMC Clinical Pathology · doi:10.1186/1472-6890-7-9 · Cited by 35
CSF-studies in neuropsychiatric disorders.
Raedler, T. J., & Wiedemann, K. (2006) · PubMed · Cited by 29
Probing genetic algorithms for feature selection in comprehensive metabolic profiling approach
Zou, W., & Tolstikov, V. (2008) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3507 · Cited by 28
The role of metabolomics in systems biology: A new vision for drug discovery and development
van der Greef, J., Davidov, E., Verheij, E. R., et al. (2003) · Kluwer eBooks · Cited by 18
Metabolomics: A Global Biochemical Approach to the Discovery of Biomarkers for Psychiatric Disorders
Kaddurah‐Daouk, R., Soares, J. C., & Quinones, M. P. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_6 · Cited by 9
Self-citationTaking the Next Steps in the Diagnosis of Alzheimer's Disease: The Use of Biomarkers
DeKosky, S. T. (2008) · CNS Spectrums · doi:10.1017/s1092852900017193 · Cited by 9
Cited by
Brunoni, A. R., Nitsche, M. A., Bolognini, N., Bikson, M., Wagner, T., Merabet, L., Edwards, D. J., Valero-Cabre, A., Rotenberg, A., Pascual-Leone, A., et al. (2012) · Brain stimulation · doi:10.1016/j.brs.2011.03.002 · Cited by 1,445
Smolinska, A., Blanchet, L., Buydens, L. M. C., & Wijmenga, S. S. (2012) · Analytica Chimica Acta · doi:10.1016/j.aca.2012.05.049 · Cited by 397
Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality
García-Gutiérrez, M. S., Navarrete, F., Sala, F., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00432 · Cited by 331
Identification of novel biomarkers for Parkinson's disease by metabolomic technologies
Hatano, T., Saiki, S., Okuzumi, A., Mohney, R. P., & Hattori, N. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309676 · Cited by 282
Potential metabolite markers of schizophrenia
Yang, J., Chen, T., Sun, L., Zhao, Z., Qi, X., Zhou, K., Cao, Y., Wang, X., Qiu, Y., Su, M., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2011.131 · Cited by 253
Metadata
- Authors
- Quinones, M. P., & Kaddurah-Daouk, R.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 35
- Issue
- 2
- Pages
- 165-176
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W1986674928
- Cited by
- 284
- References
- 95
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.